Huperzia, 'yar asalin ƙasar China, tana da kusanci da gansakuka na ƙwallon kwando kuma a kimiyance ana kiranta da Lycopodium serratum. A al'adance, ana amfani da gansakuka na stallion, amma shirye-shiryen shayi na zamani yanzu suna mayar da hankali ga alkaloid huperzine A. Wannan alkaloid, wanda aka samo a cikin huperzia, ya nuna alƙawari don hana lalacewa na acetylcholine, mai mahimmanci neurotransmitter don sadarwar intercellular a cikin tsarin juyayi. bincike akan dabba yana magana cewa huperzine A na iya zarce wasu magungunan magani a ci gaba da digiri na acetylcholine. ganin cewa asarar aikin acetylcholine shine babban sifa na rikice-rikice na kwakwalwa kamar cutar Alzheimer, huperzine A's yuwuwar tasirin neuroprotective suna sanya shi zaɓi mai ban sha'awa don sauƙaƙe alaƙar alaƙa da waɗannan yanayi.

A cikin zaɓin magani, huperzine A yana aiki azaman mai hana cholinesterase, nau'in magani wanda ke hana raguwar acetylcholine, mai mahimmanci ga hanyar fahimi kamar koyo da ƙwaƙwalwa. Bayan aikace-aikacen sa a cikin jiyya na Alzheimer, huperzine A an yi imani don haɓaka aikin fahimi, yin taka tsantsan game da raguwar fahimi masu alaƙa da shekaru, haɓaka matakin kuzari, haɓaka tsaro, da tallafawa sarrafa myasthenia gravis gravis, cuta ta autoimmune tasirin tsoka. Bambance-bambancen fa'idar yuwuwar fa'ida ga huperzine A yana nuna iyawar sa a cikin magance nau'ikan abubuwan da suka shafi kiwon lafiya masu alaƙa da aikin kwakwalwa da iyawar fahimi.

fahimtalabaran fasahaya ƙunshi bayanin zama game da haɓakawa a cikin binciken kimiyya da ƙirƙira a cikin kiwon lafiya. A cikin mahallin huperzine A, binciken da ke gudana yana iya yin bincike game da yuwuwar maganinsa, mai yuwuwar buɗe sabon aikace-aikacen wannan fili na zahiri don cire cututtukan jijiyoyin jiki da lalacewar fahimi. Kamar yadda fannin zaɓin magani ke ci gaba da haɓakawa, huperzine A tushe a matsayin mai yin kamfen don haɓaka lafiyar fahimi da magance hadaddun buƙatun mutumin da ke da yanayi kamar cutar Alzheimer da raguwar fahimi masu alaƙa da shekaru. Wajibi ne don samar da ci gaba na gaba a cikin amfani da huperzine A, yayin da yake ɗaukar alƙawari mai mahimmanci a cikin masarautar lafiyar kwakwalwa da jin daɗin jijiya.


Lokacin aikawa: Fabrairu-25-2022